3 Sickle cell disease pathophysiology

CT Noguchi, AN Schechter, GP Rodgers - Baillière's clinical haematology, 1993 - Elsevier
The primary pathophysiological event in the erythrocytes of individuals with the various
sickle syndromes is the intracellular aggregation or polymerization of sickle haemoglobin …

Protein aggregation-inhibition: a therapeutic route from Parkinson's disease to sickle cell anemia

GF Martins, N Galamba - Critical Reviews in Biochemistry and …, 2023 - Taylor & Francis
Protein aggregation is implicated in multiple diseases, so-called proteinopathies, ranging
from neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease …

Antisickling activities of two ethnomedicinal plant recipes used for the management of sickle cell anaemia in Ibadan, Nigeria

A Egunyomi, JO Moody, OM Eletu - African Journal of Biotechnology, 2009 - ajol.info
Antisickling activities of two ethnomedicinal plant recipes used for the management of sickle
cell anaemia in Ibadan, Nigeria Page 1 African Journal of Biotechnology Vol. 8 (1), pp. 020-025 …

The concepts of crossreactivity and specificity in immunology

JA Berzofsky, AN Schechter - Molecular Immunology, 1981 - Elsevier
The advent of direct binding assays for studying the interactions of immunoglobulins and
antigens has made it important to distinguish among several types of crossreactivity. The …

Tucaresol increases oxygen affinity and reduces haemolysis in subjects with sickle cell anaemia

R Arya, PE Rolan, RW OOTTON… - British journal of …, 1996 - Wiley Online Library
The primary pathophysiological event in sickling is the intracellular polymerization of
deoxygenated haemoglobin S. Tucaresol (589C80; 4 [2‐formyl‐3‐hydroxy‐phenoxymethyl] …

Physiological and x-ray studies of potential antisickling agents.

DJ Abraham, MF Perutz… - Proceedings of the …, 1983 - National Acad Sciences
Several aromatic compounds have been found to inhibit the gelling of sickle cell
hemoglobin. We have tried to correlate the antigelling activity of such compounds with the …

Sickle cell anemia and related hemoglobinopathies

EP Vichinsky, BH Lubin - Pediatric Clinics of North America, 1980 - Elsevier
Sickle Cell Anemia and Related Hemoglobinopathies Page 1 Sickle Cell Anemia and Related
Hemoglobinopathies Elliott P. Vichinsky, MD,* and Bertram H. Lubin, MDt SICKLE CELL …

[PDF][PDF] Chemical constituents and biological activity of medicinal plants used for the management of sickle cell disease-A review

KO Folashade, EH Omoregie - Journal of Medicinal Plants …, 2013 - academicjournals.org
Since 1910 when sickle cell disease was first reported by Dr. James Herrick and the
subsequent characterization by Linus Pauling who hypothesized on the nature of sickle cell …

[HTML][HTML] Expression pattern of HIF-1α and VEGF supports circumferential application of scatter laser for proliferative sickle retinopathy

M Rodrigues, F Kashiwabuchi… - … & visual science, 2016 - tvst.arvojournals.org
Purpose: Retinal vascular occlusions in sickle cell anemia patients cause tissue ischemia
and the release of angiogenic mediators that promote the development of retinal …

Overview of sickle cell anemia pathophysiology

MH Steinberg - Sickle cell anemia: from basic science to clinical …, 2016 - Springer
Sickle cell disease, caused by a mutation in the β-hemoglobin gene, is a Mendelian disorder
with a very diverse phenotype. The primary cause of disease pathophysiology is the …